This is a routine, small-dollar director sale with no material impact. Monitor for any larger insider sales or changes in the company's commercial trajectory for ZORYVE, but this filing alone does not warrant action.
Price Chart
Executive Summary
Director Patrick Burnett filed a Form 144 notice of intent to sell 955 shares of Arcutis Biotherapeutics common stock, valued at approximately $24,942. This is a small, routine sale by a director, representing a tiny fraction of the company's $3.4B market cap. The filing is neutral as it signals a planned sale but lacks material size or urgency, and no cross-filing context is present to escalate its significance.
Key Facts
- Director Patrick Burnett filed a Form 144 to sell 955 shares of ARQT common stock.
- Estimated sale value is approximately $24,942 based on the filing date.
- The shares were acquired via restricted stock vesting on August 1, 2026.
- Burnett has sold 906 shares in two prior transactions in May 2026, totaling ~$20,823.
- The sale represents less than 0.001% of Arcutis's $3.4B market cap.
Financial Impact
Director intends to sell 955 shares worth ~$24,942, a de minimis amount relative to the company's $3.4B market cap.
Risk Factors
- No material risk identified from this filing; the sale is small and routine.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-051952 |
| Document: 0001628280-26-051952-index.html | 0001628280-26-051952 |
| Document: 0001628280-26-051952.txt | 0001628280-26-051952 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 24, 2026 5w ago | Insider Cluster | $24.86 $26.38 | ▲ +6.11% | ▲ +5.87% | $25.16 (+1.21%) |
Aug 21, 2026 6w ago | Insider Cluster | $25.08 $25.96 | ▲ +3.51% | ▲ +4.04% | $25.16 (+0.32%) |
Aug 19, 2026 6w ago | Insider Cluster | $25.35 $25.38 | ▲ +0.12% | ▲ +0.12% | $25.16 (−0.75%) |
Aug 11, 2026 7w ago | 144 | $26.28 $23.38 | ▼ −11.04% | ▼ −9.14% | $25.16 (−4.26%) |
Aug 6, 2026 8w ago | Insider Cluster | $26.43 $23.66 | ▼ −10.48% | ▼ −11.08% | $25.16 (−4.81%) |
Aug 5, 2026 8w ago | Press Release | $26.43 $23.66 | ▼ −10.48% | ▼ −11.08% | $25.16 (−4.81%) |
Aug 3, 2026 8w ago | 144 | $26.03 $23.75 | ▼ −8.76% | ▼ −7.52% | $25.16 (−3.34%) |
Jun 29, 2026 13w ago | Press Release | $26.22 $27.84 | ▲ +6.18% | ▲ +7.21% | $25.16 (−4.04%) |
Jun 18, 2026 15w ago | Insider Cluster | $26.21 $27.74 | ▲ +5.84% | ▲ +5.30% | $25.16 (−4.01%) |
Jun 9, 2026 16w ago | 8-K | $23.23 $28.78 | ▲ +23.89% | ▲ +20.27% | $25.16 (+8.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access